Castleview Partners, LLC Bio N Tech Se Transaction History

Castleview Partners, LLC

  • $146 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$126.25 - $231.85 $65.7 Million - $121 Million
-520,240 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$216.64 - $362.52 $113 Million - $188 Million
519,521 Added 72256.05%
520,240 $134 Million
Q2 2021

Aug 17, 2021
BUY
$113.32 - $241.49 $81,477 - $173,631
719 New
719 $161,000

Others Institutions Holding BNTX

# of Institutions
327
Shares Held
40.4M
Call Options Held
1.31M
Put Options Held
1.37M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email